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ABSTRACT
SUPRAMOLECULAR NANOASSEMBLIES FOR THE SEPARATION AND
MASS SPECTROMETRIC ANALYSIS OF PEPTIDES AND MODIFIED
PROTEINS
SEPTEMBER 2019
MEIZHE WANG, B.S., JILIN UNIVERSITY
Ph.D., UNIVERSITY OF MASSACHUSETTS AMHERST
Directed by: Professor Richard W. Vachet

Protein post-translational modifications (PTMs) play key roles in cellular
physiology and disease, and identifying their locations on proteins can be beneficial for
understanding more deeply protein chemistry. The methods applied for PTM analysis are
most often based on mass spectrometry (MS). In the past few years, considerable progress
has been made in developing MS-based proteomics technologies for global PTM analysis.
Novel mass spectrometric peptide sequencing and analysis technologies allow for
modification site mapping at molecular level. However, detecting PTMs on proteins and
peptides by MS is challenging because of their low abundance and heterogeneity.
Therefore, separation prior to MS analysis is typically required. This dissertation describes
the use of supramolecular nanoassemblies, formed by amphiphilic polymers, as novel
enrichment tools for the detection and analysis of peptides and proteins that are
phosphorylated and glycosylated. The selectivity of the amphiphilic nanoassemblies were
changed by loading metal ions for the enrichment of phosphopeptides and by incorporating
hydrazide functional groups for the enrichment of glycopeptides. In addition to developing
new nanoassemblies for the enrichment of phosphopeptides and glycopeptides, we also
explored how supramolecular systems could be tuned to enhance extraction selectivity and
vi

efficiency via structural variations to the amphiphilic polymers. The utility of these
materials for the enrichment of phosphopeptides and glycopeptides from complexed
samples is also demonstrated.
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CHAPTER I

ANALYSIS OF POST-TRANLATIONS MODIFICATIONS BY MASS
SPECTROMETRY

Introduction

Post-Translational Modifications and Clinical Relevance
Cells need to detect and react to changes that are from inside and outside. One
strategy is by chemically modifying proteins. Proteins are the chief actors within the cell,
serving enzymatic, signaling and structural functions.1 They are formed by the end
products of gene expression, which may then undergo post-translational modifications
(PTMs), referring to the covalent cleavage or addition of modifying groups to amino acids.
These processes play key roles in sensing and responding to the conditional chemical
changes. A single PTM can re-establish the entire downstream trafficking transforming the
protein function and cell fate. Hence PTMs contribute significantly to cellular physiology
and disease.2-5
Post-translational modifications can happen at any step of the protein lifespan in
diverse ways, which may include modification short after translation to mediate proper
folding, confer stability, or translocate proteins, such as proteolysis, glycosylation,
phosphorylation, etc.6-8 Other modifications may occur after the folding and localization
for activation or inactivation of catalytic activity and functions, like the reversible
phosphorylation and the acetylation, etc.8-10 Proteins can also be post-translationally tagged
by ubiquitin for degradation.11 Besides these most common PTMs (Figure 1.1),12 there are

1

as many as 300 PTMs of proteins are known to occur physiologically, and their importance
in biological processes and disease has led them be the focus of clinical and pharmaceutical
research as potential drug targets.13-16

Figure 1.1. Types of post-translational modifications (PTMs).12

Since PTMs determine the protein-protein interactions and form the basis of some
cellular signaling pathways, which also regulate the cell–cell and cell–matrix interactions,
so they have comprised the basis of several drug targeting strategies and diagnostic tests
and been reported to have clinical relevance in disease of inflammation, host-pathogen
interactions, immune modulation, and degenerative and proliferative disorders.17-22 Among
those phosphorylation and glycosylation are the most common and well-studied posttranslational modifications (Figure 1.2).23

2

Figure 1.2. Human proteins with PTM currently available in the UnitProt database.23

Phosphorylation.

Protein

phosphorylation is one of the most
common

and

important

post-

translational modifications.24 It occurs
through kinases adding one phosphate
group (PO4) to the serine (Ser),
threonine (Thr) or tyrosine (Tyr)
residues. As a result, the protein

Figure 1.3. Mechanism of phosphorylation.

becomes hydrophilic polar, providing
the flexibility of conformational change when interacting with other molecules. The
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reversibility of protein phosphorylation by kinase and dephosphorylation by phosphatase
makes this type of PTM ideal for protein function regulation and signal transduction, as it
allows cells to respond rapidly to intracellular and extracellular stimuli.23-25 The
PhosphoSite Plus database has listed over 200,000 known human phosphorylation sites. It
is estimated that over one-third of the 21,000 proteins encoded by the human genome are
to be phosphorylated, and more than 350 phosphorylated proteins are under disease
conditions.23 Indeed, the phosphorylation events plays critical roles in the control of
biological processes such as differentiation, proliferation and apoptosis.26-28 Numerous
examples have been found. For example, in chromic myeloid leukemia, the retinoblastoma
(pRb), a kinase generated by the translocation of Philadelphia chromosome was found to
be always “on”, which leads to the proliferation of tumor cells.29 In fact, the kinase
regulated signaling pathways contribute to the start and progression of almost all types of
cancer. Another common concern is Alzheimer’s disease (AD). Back in 1980s,
hyperphosphorylated neurofibrillary tangles (NFT) was reported to be found in brains with
Alzheimer disease.30 And the detection of Tau phosphorylation in the cerebrospinal fluid
suggests the pathological mechanisms under this disease.31 In addition, the phosphorylation
of α-synuclein at S129 has been used a biomarker in dementia and Parkinson’s disease
(PD).32 Because of all these and other negative modulation of the phosphorylation, the
study of the signaling pathways regulated by kinases with blocking possibility has become
the major drug target for treatment in clinical and pharmaceutical research.
Glycosylation. Glycosylation, the attachment of sugar moieties to specific amino
acids, is another common PTM. It has been found in almost all the living organisms that
have been studied and is estimated that half of all the proteins are glycosylated.33 There are
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two major types of glycosylation: N-linked and O-linked (Figure 1.4).34 However, the
diversity that the two types of glycosylation add to the proteome to a level that is
unparalleled by any other PTMs, which allow the glycoproteins to adapt to various
functions in a wide range of biological processes, including molecule transportation,
enzyme production, cell attachment recognition, etc.35,36

Figure 1.4. The two major types of protein glycosylaiton (left) and N-linked glycosylation
(right).34

Numerous glycoproteins are N-linked that the glycans are covalently attached to
the asparagine (Asn) residue of the protein. It mostly happens when the newly translated
proteins are transported into the ER. Not all Asn can be glycosylated, but only when the
amino acid motif be Asn-X-Ser/Thr, where X can be any amino acid except Pro, then the
Asn could accept an N-glycan. All N-glycans share a common core sequence, and be
classified into three types: high mannose, hybrid and complex depending on the difference
of types of sugar units (Figure 1.4).37 There are also a variety of glycoproteins that are Olinked, which means that short glycan chains are attached to the proteins on Ser and/or Thr
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residues. Therefore, the result of protein glycosylation is a complex array of
monosaccharides or glycan structures with different glycosidic linkages (sugar-peptide
bond), glycan composition (types of sugars), glycan structure (branched or unbranched
sugar chains) and glycan length (short or long chain of oligosaccharides).
Glycoproteomics is a rapidly emerging field and its clinical relevance have been
made clear in recent years. For example, in neurodegenerative disease, the glycosylation
of acetylcholinesterase or butyrylcholinesterase has been reported as a maker of disease
progression in AD patient,38 and specific glycosylation pattern was observed in frontal
cortex in PD patient.39 Also, glycan changes have also been found in breast cancer patient
mediating the disease progression,40 and glycated haemoglobin changes have been used as
diagnostic test in diabetes.41 Therefore, glycoproteomics has been widely used for
diagnosis of various diseases. Since protein modifications influence and even define cell
functions, identifying PTMs is critical for the understanding of cell biology. Many
modification sites are implicated in the catalytic function of key enzymes, which suggests
identification of the modification sites helps the understanding of the mechanistic details
of protein-protein interactions and how PTMs modulate the protein functions.

MS Detection of PTMs
For the analysis of protein modifications, traditional strategies, such as radioactive
labeling and western blotting, can be specific and relatively quantitative, but they require
prior knowledge of the type of modification and are limited by antibody availability and
specificity. Mass spectrometry (MS), as a fast and sensitive analytical tool, become the
method of choice. It can rapidly identify proteins and provide universal information of their
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primary structures and modification without the need for prior knowledge.42-46 Currently,
there are two major complementary strategies for MS analysis of proteins PTM
identification: the bottom-up and top-down approaches (Figure 1.5).47

Figure 1.5. Protein primary structure determination by mass spectrometry.47

Bottom-Up Strategy. The bottom-up approach is the traditional proteomic
approach and has been widely used to identify proteins and determine the details of the
sequence and the PTMs.45 In this approach, proteins of interest are digested with an enzyme
like trypsin into small peptides. These peptides will first be ionized by matrix-assisted laser
desorption/ionization (MALDI) or electrospray ionization (ESI). These “soft ionization”
techniques allow peptide ions to be put into gas phase with minimal to no fragmentation
for subsequent MS analysis. Then the MALDI- or ESI-MS can provide two types of
information of the peptides. First, the peptide masses can be determined, and then the
detailed information about peptide sequence and modifications can be achieved by
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fragmenting the peptide ions in the gas phase. The bottom-up approach is especially useful
for protein identification as peptides are easily solubilized, separated and detected by MS,
which is not easy for parent proteins. Also, many peptides can be easily fragmented and
analyzed to provide enough information for the parent protein determination. Though
bottom-up strategy provides higher sensitivity than top-down (in later discussion), there
are some limitations in using bottom-up approach characterizing protein modifications.
First, there is only a fraction of the peptides that is normally detected, so the modification
in the unrecovered sequence will remain undiscovered. In addition, because the sequence
digested by trypsin are relatively small, there might be a loss of correlation that is between
modifications on different parts of the protein.45,47
Top-Down Strategy. The top-down approach is a more powerful way to analyze
unknown protein modifications as the intact protein is injected and fragmented
subsequently inside the mass spectrometer without digestion, so the molecular masses of
both the protein and all the fragment ions can be acquired and analyzed. Therefore, it is
possible to get full information of the primary structure, all the modifications of the protein,
and the relationship between amino acid sequence and modifications belonging to a
specific proteoform. This relationship cannot be preserved in bottom-up approaches
characterizing peptides after proteolytic digestion. However, it’s very important for the
understanding of biological system as different proteoforms can function very differently.
Although this strategy has shown being able to measure the molecular masses of intact
protein, it has proved challenging for top-down approach to produce extensive gas-phase
fragmentation of intact protein, especially for large proteins. Great effort has been put into
the method developments for fragmenting large proteins or peptides.47,48
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It is also worth mentioning that middle-down proteomics, as a variant of the topdown strategy, has recently emerged as a high throughput strategy in PTM
characterization.49 In this approach, the proteins are proteolyzed to large peptides, so to
preserve more sequence and modification information, and then be fragmented and
analyzed like top-down. Because of the different challenges in bottom-up and top-down
approaches and depending on the different questions that researchers try to answer, the two
approaches are still coevolving.47
Mass Spectrometry Fragmentation Strategies. In MS-based protein detection,
tandem mass spectrometry (MS/MS) is the key technique for protein and peptide
sequencing and PTM analysis.50 It is essential to have proper fragmentation to produce
enough fragment ion information for the sequence identification and modification site
localization. There are several fragmentation methods available, including collisioninduced dissociation (CID), electron-capture dissociation (ECD), electron-transfer
dissociation (ETD) and higher energy collisional dissociation (HCD).51
CID, also known as collisionally activated dissociation (CAD), has been the most
widely used MS/MS technique. In this dissociation method, gas phase peptide or protein
cations are heated by collisions with rare gas atoms, resulted in fragmentation of C-N bond
in the peptide backbone, producing a series of b- and y-fragment ions. This method is not
friendly for labile PTMs because of the slow-heating and high energy required in the
fragmentation process. Other internal fragmentation and neutral loss of H2O or NH3 can
also occur. And this technique usually works for small peptides (< 15 amino acids).52,53
A later developed fragmentation technique, ECD, works by capturing a thermal
electron causes the protonated peptide or protein cation be fragmented on the N-Cα bond,
9

resulting in a series of c- and z-fragments ions. ECD can preserve the labile modifications
and provide more extensive fragmentation and higher sequence coverage, thus become a
powerful technique but mostly constrained to the expensive and sophisticated FTICR
instruments.54
ETD is a similar technique to ECD but could be more commonly used in bench top
mass spectrometers. In this method, the electrons transfer from radical anions with low
electron affinity to protonated peptide or protein cations, to produce fragmentation
resulting in c- and z-types of ions. It is very complementary to conventional CID in
analyzing very large peptides because of its higher efficiency and has shown great potential
in labile PTM analysis.55

PTM Enrichment Strategies
The bottom-up proteomics, such as shotgun proteomics, provide high sensitivity in
characterizing modifications after protein proteolysis. Although the mass spectrometers
have evolved dramatically in recent decades, it is still impossible to directly identify most
of the PTMs in a standard MS analysis from complex protein digests. The general
workflow for protein PTM analysis always includes efficient peptide enrichment prior to
MS detection because of the low abundance of modified proteins and low stoichiometry of
PTMs. The presence of huge amount of unmodified peptides significantly suppresses the
detection of modified peptides.56,57
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Figure 1.6. Major strategies for enrichment of PTM peptides.56

Various available enrichment methods can be divided into two types: chemical
approaches and biochemical approaches (Figure 1.6),56 where chemical approaches make
use of the different chemical properties of modified and unmodified peptides while
biochemical approaches utilize the specific interactions between biomolecules. In the first
approach, for example, chromatography-based methods, such as immobilized metal ion
affinity chromatography (IMAC) and hydrophilic interaction chromatography (HILIC),
enrich phosphopeptides and glycopeptides because that phosphate groups have higher
affinity to metal ions and glycosylated peptides are more hydrophilic than non-modified
peptides. Also, glycopeptide enrichment can be enriched by hydrazide chemistry because
11

oxidized glycans can react with hydrazide groups while non-glycopeptides cannot.
Biochemical approaches, however, are based on the specific recognition of enzyme and
substrate, such as enzymatic labelling methods, of antibody and antigen, like
immunoaffinity purification. The enzymatic labeling methods have been used for
enrichment of peptides with O-GlcNAc and S-glutathionylation, and immunoaffinity
purification has been applied for a bunch of PTM peptide enrichment, such as acetylation,
methylation, ubiquitination and phosphorylation. Chemical approaches, providing more
flexibility and universality, has been kept developing and optimizing to acquire more indepth PTMs information, which can be clearly seen in the evolution of phosphopeptide
enrichment (Figure 1.7).56

Figure 1.07. Evolution of phosphopeptide enrichment methods.56
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Conventional IMAC for the enrichment of phosphopeptides is based on the
chelating interactions between phosphate group and metal ions that are immobilized on
solid beads with iminodiacetic acid (IDA) or nitrilotriacetic (NTA) as the chelating groups.
Fe3+ was the initial metal ions, and then a lot of ions, such as Ni2+, Ga3+, Gu2+, Co2+, Al3+,
etc. have been applied to IMAC.58 This conventional IMAC has been developed for a long
time but still suffer a great challenge of non-specific binding from Glu and Asp. This
problem was tried to be overcome by the methyl esterification of carboxyl groups on Asp
and Glu prior to phosphopeptide enrichment.59 However, this method was rarely used
because of the incomplete esterification, side reaction and possible peptide loss, then
optimizing loading buffer became a more practical and simple way to improve the
enrichment specificity. Higher selectivity could be achieved by protonating the carboxylic
groups on Asp and Glu, while leaving the phosphate groups deprotonated in the loading
buffer of pH 2-2.5 as the pKa of E and D is around 4 while of phosphate group is about
2.60 Later the conventional IMAC was mostly replaced by the metal oxide affinity
chromatography (MOAC) especially in large-scale phosphoproteome studies, because of
the higher enrichment efficiency and easier availability shown by ZrO2 and TiO2.61 More
recently, a new type of IMAC that tries to combine the advantages of IMAC and MOAC
has been developed, where Zr4+ and Ti4+ are used as the chelating metal ions because of
the higher specificity between metal (IV) ions and phosphate groups than that of
conventional IMAC metal ions. In addition, compared to MOAC, Zr4+- or Ti4+-IMAC
shows higher efficiency because of the flexible arms introduced in IMAC that can reduce
the steric hindrance.62,63 Based on that, some new matrix materials have been developed to
further improve their enrichment efficiency. Among those, incorporating nanomaterials
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has become the most attractive method as it can provide higher surface area for higher
capacity and can be easily modified on the material surface and on the chelating ligands
for simple optimization.64-66

Supramolecular Nanoassemblies as Selective Extraction Agents for MS Analysis of
PTMs
Supramolecular nanoassemblies, including micelles, reverse micelles, vesicles,
polymersomes, and gels, have been widely studied for encapsulation, detection, and
targeted delivery of biomolecules.67,68 A key characteristic of supramolecular systems is
their ability to be tuned via changes at the molecular level. Non-covalent interactions,
including electrostatic interactions, H-bonding, π-π stacking, metal-ligand coordination,
and general host-guest interactions, are often used for this purpose.69,70 Supramolecular
assemblies formed by amphiphilic polymers as enrichment agents for the selective
detection of biomolecules through electrostatic interactions have been explored in our
group. These amphiphilic polymers, either homopolymers or copolymers, consist of
hydrophobic and functional hydrophilic moieties that can self-assemble into reverse
micelles in apolar solvents. Once assembled, they act as nanocontainers that selectively
enrich biomolecules from aqueous solution into their interiors, by bringing them across the
solution-solution interface (Figure 1.8).71-81
These nanoassemblies have shown great features for biomarker extraction. 1) They
can be easily synthesized and can be widely used by changing the functional groups based
on the property of target biomolecules. For example, to target positively-charged peptides
or proteins, carboxylate, sulfonate or phosphonate-containing polymers can be synthesized,
either as homopolymers or random co-polymers, and for negatively-charged peptides or
14

proteins, the hydrophilic part of polymer can be replaced as positively-charged quaternary
amine groups.71,72,79,80 2) After the functional groups recognize and bind with the peptides
or proteins of interest via two-phase liquid-liquid extraction, they can be easily collected
in the organic phase because they tend to be trapped only in the toluene phase where they
are initially assembled. The use of two immiscible phases allows easy isolation of the
extracted peptides after centrifugation.77 3) Enhanced detection has been observed which
is significant for the detection of usually low-abundant biomarkers. The MALDI signal
enhancement was found to be due to the donor-acceptor and electrostatic interactions in
the supramolecular systems during MS analysis, where the donor-acceptor interactions
drive a formation of ternary assembly of the polymer, peptide and matrix, which produces
peptide-rich zones or ‘hot spots’ that maximize the ion signal in the mass spectrum.76
Detection of peptides of interest can also be enhanced by selective removal of interfering
peptides or proteins using the corresponding polymers. For example, abundant acidic
proteins in serum can be depleted using positively-charged polymers and so allow for the
enhanced detection of higher pI proteins.78 This depletion efficiency can be further
improved by varying the polymer structure, concentration and charge density.79,80 4) A
systemic study of how polymer structure influences extraction shows that the inherent
feature of the functional group of the polymer like its pKa affects not only selectivity as in
free aqueous solution, but also affects the extraction capacity because of the hydrophiliclipophilic balance (HLB) of the polymer, which allows the materials to be used as a more
predictable separation method.79 These fundamental studies have given us insight that has
allowed us to extract peptides with specific pI values,72,73 generate titration curves for
individual peptides in a mixture,74 efficiently release peptides for quantitative analysis,81
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enrich biomarkers in human serum and breast milk by specific pI bracketing, and reduce
sample complexity with concurrent pI bracketing for high sensitive MS detection of the
biomarkers of interest.75,78

Figure 1.8. Amphiphilic polymers self-assemble into micelle-type assembly or reverse
micelle-type assemblies, which can be used for two-phase liquid-liquid extraction of
peptides prior to MS analysis.72

While these supramolecular materials have been effective at enriching molecules
based on complementary charge, the electrostatic interaction-based affinity cannot satisfy
the need for the selectivity of extracting modified peptides. To study a wider range of
biomolecules, altering the selectivity of these promising materials is an important goal in
this dissertation. In chapter II, a simple approach for changing the enrichment selectivity
of these materials instead of synthesizing new functional polymers has been explored,
which is via the addition of metal ions. A series of polymer with varying phosphonate
architecture have been synthesized and loaded with different amount of Zr4+ and their
16

extraction performance have been studied. With the best selectivity and efficiency achieved
by certain polymer and ratio to metal ions, these materials are used for selectively enrich
phosphorylated peptides present in low levels in protein mixtures.
Although non-covalent interactions have proved successful in extraction, the
selectivity achieved by non-covalent bond cannot be competitive to that of covalent bonds,
as non-specific interactions can be washed off thoroughly. In chapter III, we used covalent
binding via hydrazide groups to achieve high selectivity for glycopeptide. At the same time,
a non-covalent interaction was incorporated to catalyze this normally slow covalent
binding reaction, thereby improving extraction efficiency. We find that in the confined
environment of the nanoassembly the reaction of hydrazide with glycans is faster than in
existing approaches. Moreover, the extraction efficiency can be further increased by
placing functional groups in the assemblies that catalyze the reaction of hydrazide moieties
with glycans.
In chapter IV, another effective way of expanding the scope of the material’s
selectivity is demonstrated. Besides of selective extraction using the nanomaterials, we add
another dimensional control over the peptide separation, which is controlled release. The
release behavior of the peptides from nanoassemblies into stripping buffer has been studied,
and it shows great potential in isolating desired peptides after peptide synthesis.
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CHAPTER II

SUPRAMOLECULAR NANOASSEMBLIES FOR PHOSPHOPEPTIDE
ENRICHMENT

The majority of this chapter was published in Wang, M.; Zhao, B.; Gao, J.; He, H.;
Castellanos, L.J.; Thayumanavan, S.; Vachet, R. W. Altering the Peptide Binding
Selectivity of Polymeric Reverse Micelle Assemblies via Metal Ion Loading. Langmuir
2017, 33, 14004-14010.

Figure 2.1. Langmuir journal cover of selective extraction of phosphopeptides by Zr(IV)loaded polymeric reverse micelles.
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Introduction
Supramolecular nanoassemblies formed by amphiphilic polymers have been
proved very effective at enriching molecules based on complementary charge,

1-6

altering

the selectivity of these promising materials is an important goal that typically requires
synthesis of new functional polymers. In this chapter, we have explored a simpler approach
for changing the enrichment selectivity of these polymeric reverse micelles via the addition
of metal ions. We find that by loading the reverse micelles with Zr ions, we can
dramatically change the selectivity of the materials so that they specifically bind
phosphopeptides (Figure 2.1). Further tuning of the selectivity and efficiency of the
enrichment process can be accomplished by varying the polymer architecture. The
resulting materials can selectively enrich phosphorylated peptides, which are present in
low-levels in protein mixtures, thereby offering a potentially new approach for studying
protein phosphorylation, which is important for a variety of biological phenomena.7-11

Figure 2.2. Schematic illustration of polymeric reverse micelles having phosphonate
functional groups loaded with Zr(IV) that can selectively bind phosphopeptides.
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Results and Discussion
An aqueous phase peptide mixture created by digestion of the proteins α-casein, βcasein, chicken ovalbumin, bovine serum albumin (BSA), and lysozyme was extracted
using reverse micelles of polymer P1, containing phosphonate moieties (Figure 2.2), and
analyzed by MALDI-MS (Figure 2.3). Before extraction, the mass spectrum (Figure 2.3a
and Table 2.1) is dominated by peptides with low pI values, which is consistent with the
fact that four of the five proteins are acidic. After extraction using polymer P1, peptides
with pI values close to or above the aqueous solution pH of 7 are detected (Figure 2.3b and
Table 2.2), which is consistent with our previous work that showed reverse micelles of
negatively charged polymers extract positively charged peptides.1-6

Figure 2.3. Chemical structures of amphiphilic random copolymers P1-P4 and
amphiphilic homopolymer P5.

The goal of the current work is to test whether the selectivity of these polymers
could be varied by the simple addition of something to the reverse micelle solution. To test
this idea, we loaded the reverse micelle interiors with Zr(IV), which has high affinity for
phosphate groups. We hypothesized that the addition of this metal would convert the
interior from being negatively-charged to an interior that presented coordinated Zr(IV) ions
capable of selectively binding phosphopeptides. We were indeed pleased to find that upon
extracting the same protein digest, which contains three phosphoproteins (i.e. α-casein, β-

27

casein, and ovalbumin), the polymer assembly’s selectivity changes dramatically. The
mass spectrum is now dominated by phosphopeptides (Figure 2.3c and Table 2.3),
indicating that the driving force for extraction has been converted from electrostatic
interactions to Zr(IV)-phosphate interactions. It should be stated that the extraction with
the Zr(IV)-loaded polymer is selective for phosphopeptides and not just acidic peptides, as
positively charged polymer P5 extracts acidic peptides, including non-phosphorylated ones
(Figure 2.3d and Table 2.4).

Figure 2.4. MALDI mass spectra of a protein digest mixture of α-casein, β-casein, chicken
ovalbumin, bovine serum albumin (BSA) and lysozyme each at 0.5 μM, acquired in the
negative ion mode (a) before enrichment, (b) after enrichment at pH 7 using reverse
micelles of polymer P1, (c) after enrichment at pH 7 using reverse micelles of polymer P1
loaded with Zr(IV), and (d) after enrichment at pH 7 using reverse micelles of polymer P5.
The numbers above the peaks indicate the calculated pI values of the peptides, and the
asterisks indicate the phosphorylated peptides.
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Table 2.1. Most abundant peptides detected from protein mixture consisting of α-casein,
β-casein, chicken ovalbumin, BSA and lysozyme by MALDI-TOF-MS analysis in negative
mode before enrichment.
Peptide sequence
YLGYLEQLLR
FFVAPFPEVFGK
SLHTLFGDELCK
DAFLGSFLYEYSR
GGLEPINFQTAADQAR
DSTRTQINKVVRFDK
ELINSWVESQTNGIIR
LFTFHADICTLPDTEK
RHPYFYAPELLYYANK
VTEQESKPVQMMYQIGLFR
LPGFGDSIEAQCGTSVNVHSSLR
FDKLPGFGDSIEAQCGTSVNVHSSLR
ELEELNVPGEIVESLSSSEESITR
RELEELNVPGEIVESLSSSEESITR

pI
6.00
6.00
5.30
4.37
4.37
9.99
4.53
4.54
8.39
6.92
2.84
1.88
1.55
1.48

[M-H]- (Da)
1265.7
1382.7
1417.7
1565.7
1685.8
1805.0
1857.0
1905.9
2043.0
2282.1
2509.1
2889.3
2963.3
3120.5

Protein
α-casein
α-casein
BSA
BSA
ovalbumin
ovalbumin
ovalbumin
BSA
BSA
ovalbumin
ovalbumin
ovalbumin
β-casein
β-casein

Table 2.2. Positively charged peptides detected from protein mixture consisting of αcasein, β-casein, chicken ovalbumin, BSA and lysozyme by MALDI-TOF-MS analysis in
negative mode after enrichment using polymer P1 at pH 7.
Peptide sequence

pI

HIATNAVLFFGR
YLGYLEQLLRLKKYK
RHPYFYAPELLYYANK
VTEQESKPVQMMYQIGLFR
VHHANENIFYCPIAIMSALAMVYLGAK

9.76
9.70
8.39
6.92
7.24
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[M-H](Da)
1343.7
1926.1
2043.0
2282.1
3031.5

Protein
ovalbumin
α-casein
BSA
ovalbumin
ovalbumin

Table 2.3. Phosphopeptides detected from protein mixture consisting of α-casein, β-casein,
chicken ovalbumin, BSA and lysozyme by MALDI-TOF-MS analysis in negative mode
after enrichment using Zr loaded polymer P1 at pH 7.
No. of
phosphorylation
Peptide sequence
sites
TVDMESTEVFTK
1
TVD[Mo]ESTEVFTK
1
VPQLEIVPNSAEER
1
YLGEYLIVPNSAEER
1
DIGSESTEDQA[Mo]EDIK
2
YKVPQLEIVPNSAEER
1
FQSEEQQQTEDELQDK
1
EVVGSAEAGVDAASVSEEFR
1
LPGFGDSIEAQCGTSVNVHSSLR
1
FDKLPGFGDSIEAQCGTSVNVHSSLR
1
ELEELNVPGEIVESLSSSEESITR
4
RELEELNVPGEIVESLSSSEESITR
4
[Mo], Oxidation on methionine; S: phosphorylated residue.

[M-H](Da)
1464.6
1480.6
1658.8
1830.9
1941.7
1950.0
2059.8
2087.9
2509.1
2889.3
2963.3
3120.5

Protein
α-casein
α-casein
α-casein
α-casein
α-casein
α-casein
β-casein
ovalbumin
ovalbumin
ovalbumin
β-casein
β-casein

Table 2.4. Negatively charged non-phosphorylated peptides detected from protein mixture
consisting of α-casein, β-casein, chicken ovalbumin, BSA and lysozyme by MALDI-TOFMS analysis in negative mode after enrichment using positively charged polymer P5 at pH
7.
Peptide sequence
YLGYLEQLLR
TVMENFVAFVDK
DAFLGSFLYEYSR
LKPDPNTLCDEFK
DAFLGSFLYEYSR
AEFVEVTKLVTDLTK

[M-H]- (Da)
1265.7
1397.7
1565.7
1517.7
1565.7
1690.9

pI
6.00
4.37
4.37
4.56
4.37
4.68

Protein
α-casein
BSA
BSA
BSA
BSA
BSA

The Zr(IV)-polymer assemblies were characterized in several ways to assess the
nature of the resulting materials. First, DLS of the polymers in toluene with and without
Zr(IV) demonstrate the formation of assemblies with narrow size distributions (Figure 2.4a)
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that change from about 90 nm to 120 nm upon adding Zr. These sizes are consistent with
the sizes of polymeric reverse micelles that have been studied previously.12,13 Measuring
the sizes of the assemblies after extraction of the aqueous phase is complicated by the
formation of a interfacial layer between the phases. Second, complexation of Zr by the
phosphonate groups in polymer P1 was confirmed by FT-IR measurements (Figure 2.4b).
After loading metal, the P=O stretch of the phosphonate group shifts from 1241 cm-1 to
1192 cm-1, which is consistent with coordination between Zr(IV) and the phosphonate
group causing the formation of longer P-O bonds in the polymer.14,15 The disappearance of
the 993 cm-1 band and appearance of a new band around 948 cm-1 in the Zr-loaded
polymer suggests the replacement of P-O-H with P-O-Zr. Third, the concentration of Zr in
the polymeric assemblies, as assessed by ICP-MS (Table 2.5), confirm that (i) Zr is present
in the polymer assemblies, as Zr itself is not soluble in toluene alone, and (ii) the Zrphosphonate stoichiometry can be varied by changing the amount of Zr that is added.

Figure 2.5. (a) DLS of polymer P1 (black) and Zr loaded polymer P1 (red) in toluene at
concentrations of 0.1 mM in terms of phosphonate groups. (b) FT-IR of polymer P1
(black) and Zr loaded polymer P1 (red) after drying the solutions from toluene.
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Table 2.5. ICP-MS determined Zr concentrations of the polymer-containing toluene phase
upon adding 0.07 mg/mL of polymer P1 (100 µM phosphonate groups) and different molar
ratios of Zr.
Added Zr/P
ratio

Measured Zr/P ratio

0

0*

0.1

0.0187 ±0.0008

0.2

0.058 ±0.002

0.5

0.239 ±0.005

1

0.58 ±0.01

2

1.21 ±0.02

5

2.69 ±0.05

* Zr concentrations are below detectable levels.

We next studied how Zr(IV) loading influenced phosphopeptide binding selectivity
and efficiency for polymer P1. Selectivity is reported as the percentage of detected peptides
that are phosphopeptides and provides a measure of the specificity of the enrichment
process. We used total phosphopeptide intensity as an indicator of the efficiency of the
enrichment process, as a greater number of enriched phosphopeptides should give rise to
higher MALDI-MS ion signals. It was found that the selectivity levels off when the
polymer is loaded with a 0.5 Zr/P ratio (Figure 2.5a). Presumably, this amount of Zr is the
minimum amount necessary to shield the effect of the negatively charged phosphonate
groups in the reverse micelles such that positively charged peptides are no longer
selectively extracted. Interestingly, further increases in the Zr/P ratios up to about 3 lead to
greater enrichment efficiencies (Figure 2.5b), suggesting that increases in Zr
concentrations lead to more open coordination sites for phosphopeptide binding. Increases
in Zr/P ratios beyond 3 cause decreases in extraction efficiency. This effect might arise due
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to MALDI-MS signal suppression in the presence of higher Zr concentrations or
overloading of the reverse micelles that lead to leaching of Zr back into the aqueous phase
during the two-phase extraction process. In the latter case, presumably free Zr in the
aqueous phase could form complexes with phosphopeptides,16 thereby decreasing the
efficiency with which they are extracted into the reverse micelles. Support for this idea is
found upon measuring the Zr concentration in the aqueous phase after extraction. When
the Zr/P ratio is 5, 12.0 ±0.4% of the added Zr ends up back in the aqueous phase, whereas
only 0.21 ±0.01% to 3.00 ±0.03% of the added Zr is found in aqueous phase when the Zr/P
ratio is between 0.5 and 3.0.

Figure 2.6. (a) Selectivity and (b) efficiency of extracting phosphopeptides from a protein
digest mixture of α-casein, β-casein and chicken ovalbumin each at 0.5 μM at pH 7 using
polymer P1 loaded with Zr at different molar ratios of Zr/P.

We then investigated whether the binding selectivity could be further tuned by
varying the phosphonate composition of the polymer. We hypothesized that there would
be an optimal number of phosphonate groups that would yield the proper balance between
immobilizing Zr inside the reverse micelle assemblies while providing replaceable
coordination sites for phosphopeptide binding. To test this idea, we designed a series of
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random copolymers P1-P4 (Figure 2.2) having different percentages of phosphonate and
PEG groups. The PEG groups were chosen to act as weak Zr coordination sites that could
be replaced by phosphopeptides.
Phosphopeptide enrichment selectivity and efficiency was found to be the highest
when the random co-polymers had both phosphonate and PEG groups (P1 and P2), rather
than just phosphonate groups or just PEG groups (Figure 2.6). For example, at pH 7
polymers P1 and P2 are very selective with percentages of 89 ±8 and 81 ±7, respectively,
whereas polymers P3 and P4 (without the PEG-based co-monomer and the phosphonatebased monomer in the polymer respectively) have selectivity percentages of 36 ±9 and 36
±5, respectively. Likewise, polymers P1 and P2 more efficiently extract phosphopeptides
as indicated by the higher phosphopeptide intensities (Figure 2.6b). The relatively low
enrichment selectivity and efficiency of polymer P3 are attributed to the inability of some
of the polymer phosphonate groups to be displaced from Zr(IV) inside the reverse micelles
upon exposure to phosphopeptides, resulting in inefficient phosphopeptide capture. The
low enrichment selectivity and efficiency for polymer P4 might be caused by the poor
coordinating ability of the PEG groups such that Zr(IV) does not remain stably bound
inside the reverse micelles upon exposure to the phosphopeptides, thereby preventing
efficient peptide capture. Evidence for this idea comes from ICP-MS measurements of the
aqueous phase after extraction. When P4 is used for extraction, 16.5 ±0.5% of the added
Zr is found in the aqueous phase, whereas for polymers P1, P2, and P3 3.00 ±0.03%, 2.73
±0.07%, and 1.64 ±0.02%, respectively are found in the aqueous phase. Overall, polymers
P1 and P2 seem to provide the right balance of Zr(IV) coordination strength and the ability
to open up coordination sites for entering phosphopeptides. It should be noted that an
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analogous effect has been observed in immobilized metal affinity chromatography, where
an optimum coordination number for the immobilized metal leads to more efficient
extractions.16
Another interesting feature of these materials is that their selectivity and efficiency
are somewhat independent of pH (Figure 2.6), emphasizing the role that Zr-phosphate
interactions play in the binding selectivity. Moreover, this behavior contrasts with most
immobilized metal affinity approaches that suffer from Zr(IV) hydrolysis at higher pH
values and thus only work well under acidic conditions.7-11 Perhaps the confined
environment inside the reverse micelles limits hydroxide levels, thereby minimizing
hydrolysis.

Figure 2.7. Phosphopeptide enrichment (a) selectivity and (b) efficiency using the
polymers P1-P4 in Scheme 2 to extract a three-protein digest mixture from an aqueous
phase pH of 3, 5 and 7.

Upon better understanding the polymer features that influence phosphopeptide
binding, we explored the scope of the binding specificity by extracting phosphopeptides
from digests of the phosphoprotein β-casein in the presence of 10 and 100-fold molar
excesses of BSA. Before extraction of the protein digest mixture, analysis by MALDI-MS
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reveals a spectrum dominated by numerous non-phosphorylated peptides originating from
BSA (Figure 2.7a). The presence of exclusively BSA-related peptides is not surprising as
digestion of this protein can produce more than 200 peptides, while β-casein typically
produces only 20 peptides, of which only 3 are phosphorylated. Upon using polymer P1 or
P2 to enrich the phosphopeptides of β-casein, MALDI-MS spectra are now much simpler
with 3 or 2 phosphopeptides detected (Figure 2.7b and c, respectively). These results
highlight the high degree of selectivity possible when Zr(IV) is loaded into these polymeric
reverse micelles.

Figure 2.8. MALDI mass spectra of protein digests of β-casein and BSA (a) before
enrichment; (b) after enrichment using Zr loaded polymer P1 and a β-casein: BSA ratio of
1:10 (β-casein 50 nM; BSA 0.5 μM) at pH 7; (c) after enrichment using Zr loaded P2 and
a β-casein: BSA ratio of 1:100 (β-casein 10 nM; BSA 1 μM) at pH 3. The peaks labeled
with asterisks indicate the phosphorylated peptides.

Conclusions
We have developed a simple method of varying the binding selectivity of polymeric
reverse micelles by changing the chemistry of their interiors via the addition of Zr(IV) ions.
Metal addition resulted in reverse micelle capable of selectively enriching phosphopeptides
from protein digest mixtures. We further tuned the selectivity of these materials by varying
the ratio of hydrophilic functional groups in the reverse micelle interior and found that a
combination of PEG groups and phosphonate groups provided the optimum binding
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selectivity and efficiency. Finally, the optimized polymer structure, loaded with Zr(IV)
ions, allowed us to selectively bind phosphorylated peptides that are present at very low
levels in a more complicated sample. This study demonstrates that supramolecular
materials based on polymeric reverse micelles can be readily designed to selectively target
biomolecules of interest. Future work will further develop these Zr(IV)-loaded polymers
so that it can be used to improve the detection of phosphopeptides, which could make them
valuable materials for phosphoproteomics studies.
Experimental Methods

Materials and Reagents
α-Casein, β-casein, chicken ovalbumin, BSA, lysozyme, DL-dithiothreitol (DTT),
iodoacetamide (IAM), phosphoric acid (H3PO4), and zirconium(IV) oxychloride
octahydrate (ZrOCl2·8H2O) were obtained from Sigma-Aldrich. 2, 5-dihydroxybenzoic
acid (DHB), Tris hydrochloride, toluene, and tetrahydrofuran (THF) were purchased from
Fisher Scientific. Trypsin was obtained from Promega. Urea was purchased from MP
Biomedicals. Ammonium bicarbonate (NH4HCO3) was obtained from Fluka. Water was
purified using a Milli-Q water purification system (Millipore, Bedford, MA). All other
chemicals were used as obtained from commercial sources.

Polymer Synthesis
The amphiphilic random copolymers bearing hydrophobic p-alkoxy moieties and
hydrophilic variable phosphonate, pentaethylene glycol monomethyl ether (PEG), or
carboxylate groups that were used in this study are shown in Figure 2.2. All monomers
were synthesized through Wittig reactions of the corresponding aldehydes and the
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polymerizations were carried out using nitroxide mediated radical polymerization (NMP).
The molecular weight of each polymer was measured by gel permeation chromatography
(GPC). The ratios of repeating units in each polymer were calculated by nuclear magnetic
resonance (NMR).

Figure 2.9. Synthetic scheme for monomer M2.

Synthesis of Monomers. Synthesis of compound M1: To a solution of acetone
mixed with K2CO3 (11.84 g, 85.65 mmol) and 18-crown-6 (1.13 g, 4.28 mmol), 4hydroxybenzaldehyde (5.23 g, 42.83 mmol) was added and stirred for 5 min. To this
mixture, 1-bromodecane (14.21 g, 64.24 mmol) was added and stirred at reflux for 20 h.
The reaction mixture was then cooled to room temperature and filtered to afford the crude
product in acetone solution. The solvent was evaporated to dryness and purified by silica
gel column chromatography (8-10% ethyl acetate in hexanes) to obtain 10.5 g (95% yield)
of M1. 1H NMR (400MHz, CDCl3) δ 9.86 (s, 1H), δ 7.80-7.82 (d, 2H), δ 6.96-6.99 (d, 2H),
δ 4.00-4.04 (t, 2H), δ 1.76-1.83 (quint, 2H), δ 1.47-1.26 (m, 14H), δ 0.85-0.89 (t, 3H); ESIMS (expected: [m+H]+= 263.2, obtained: [m+H]+= 263.2).
Synthesis of monomer M2: Methyltriphenylphosphonium bromide (6.58 g, 25.11
mmol) and potassium tert-butoxide (3.94 g, 35.15 mmol) were mixed in a round bottom
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flask, and dry THF (20 mL) was added to the mixture. The mixture was stirred under argon
atmosphere in an ice bath for 15 min to yield a bright yellow solution. M1 (6.58 g, 25.11
mmol) was slowly added to the mixture. The reaction mixture was further stirred for 5 h.
After the reaction, saline and ethyl acetate were added for extraction. The combined
organic layer was separated and washed with saline (3 x). The organic layer was evaporated
to dryness and purified by silica gel column chromatography (3-5% ethyl acetate in
hexanes) to afford 5.5 g (85% yield) of M2. 1H NMR (400MHz, CDCl3) δ 7.31-7.33 (d,
2H), δ 6.83-6.85 (d, 2H), δ 6.61-6.68 (q, 1H), δ 5.57-5.61 (d, 1H), δ 5.09-5.12 (d, 1H), δ
3.93-3.96 (t, 3H), δ 1.73-1.80 (quint, 2H), δ 1.27-1.46 (m, 14H), δ 0.86-0.89 (t, 3H); ESIMS (expected: [m+H]+= 261.2, obtained: [m+H]+= 261.2).

Figure 2.10. Synthetic scheme for monomer M4.

Synthesis of compound M3: To a solution of acetone mixed with K2CO3 (1.17 g,
8.45 mmol), and 18-crown-6 (0.56 g, 2.11 mmol), 4-hydroxybenzaldehyde (0.52 g, 4.23
mmol) was added and stirred for 5 min. To this mixture, tosylate of pentaethyleneglycol
monomethyl ether (2.06 g, 5.07 mmol) was added and stirred with reflux for 20 h. The
reaction mixture was then cooled to room temperature and filtered to afford the crude
product in acetone solution. The solvent was evaporated to dryness and purified by silica
gel column chromatography (3-5% MeOH in DCM) to obtain 1.0 g (65% yield) of M3. 1H
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NMR (400MHz, CDCl3) δ 9.88 (s, 1H), δ 7.82-7.84 (t, 2H), δ 7.01-7.03 (d, 2H), δ 4.204.22 (t, 2H), δ 3.88-3.90 (t, 2H), δ 3.53-3.73 (m, 16H), δ 3.37 (s, 3H); ESI-MS (expected:
[m+H]+= 357.2, obtained: [m+Na]+= 379.2).
Synthesis of monomer M4: Methyltriphenylphosphonium bromide (1.35 g, 3.79
mmol) and potassium tert-butoxide (0.42 g, 3.74 mmol) were mixed in a round bottom
flask, and dry THF (15 mL) was added to the mixture. The mixture was stirred under argon
atmosphere in an ice bath for 15 min to yield a bright yellow solution. M3 (0.9 g, 2.53
mmol) was slowly added to the mixture. The reaction mixture was further stirred for 5 h.
After the reaction, saline and ethyl acetate were added for extraction. The combined
organic layer was separated and washed with saline (3 x). The organic layer was evaporated
to dryness and purified by silica gel column chromatography (30-40% ethyl acetate in
hexanes) to afford 0.54 g (60% yield) of M4. 1H NMR (400MHz, CDCl3) δ 7.31-7.32 (d,
2H), δ 6.85-6.86 (d, 2H), δ 6.61-6.67 (q, 1H), δ 5.57-5.61 (q, 1H), δ 5.09-5.12 (q, 1H), δ
4.10-4.12 (t, 2H), δ 3.83-3.85 (t, 2H), δ 3.53-3.72 (m, 16H), δ 3.37 (s, 3H); ESI-MS
(expected: [m+H]+= 355.2, obtained: [m+Na]+= 377.2).

Figure 2.11. Synthetic scheme for monomer M6.

Synthesis of compound M5: To a solution of acetone mixed with K2CO3 (6.79 g,
49.13 mmol), NaI (7.36 g, 49.13 mmol) and 18-crown-6 (0.65 g, 2.46 mmol), 4-
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hydroxybenzaldehyde (3.00 g, 24.57 mmol) was added and stirred for 5 min. To this
mixture, tert-butyl-bromoacetate (9.58 g, 49.13 mmol) was added and stirred with reflux
for 20 h. The reaction mixture was then cooled to room temperature and filtered to afford
the crude product in acetone solution. The solvent was evaporated to dryness and purified
by silica gel column chromatography (10-13% ethyl acetate in hexanes) to obtain 5.5 g (95%
yield) of M5. 1H NMR (400MHz, CDCl3) δ 9.88 (s, 1H), δ 7.82-7.84 (d, 2H), δ 6.97-6.99
(d, 2H), δ 4.59 (s, 2H), δ 1.47 (s, 9H); ESI-MS (expected: [m+H]+= 237.1, obtained:
[m+Na]+= 259.1).
Synthesis of monomer M6: Methyltriphenylphosphonium bromide (7.94 g, 22.24
mmol) and potassium tert-butoxide (2.50 g, 22.24 mmol) were mixed in a round bottom
flask, and dry THF (15 mL) was added to the mixture. The mixture was stirred under argon
atmosphere in an ice bath for 15 min to yield a bright yellow solution. 1c (3.5 g, 14.83
mmol) was slowly added to the mixture. The reaction mixture was further stirred for 5 h.
After the reaction, saline and ethyl acetate were added for extraction. The combined
organic layer was separated and washed with saline (3 x). The organic layer was evaporated
to dryness and purified by silica gel column chromatography (3-5% ethyl acetate in
hexanes) to afford 3.1 g (90% yield) of M6. 1H NMR (400MHz, CDCl3) δ 7.33-7.35 (d,
2H), δ 6.84-6.87 (d, 2H), δ 6.63-6.68 (q, 1H), δ 5.60-5.64 (q, 1H), δ 5.13-5.15 (q, 1H), δ
4.51 (s, 2H), δ 1.49 (s, 9H); ESI-MS (expected: [m+H]+= 235.1, obtained: [m+Na]+=
257.1).
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Figure 2.12. Synthetic scheme for random copolymer P1-P4.

Synthesis of Polymers. Synthesis of polymers 1a-3a and P4: A mixture of the
compound M2 (200 mg, 0.77 mmol), M4 (109 mg, 0.31 mmol), commercial available
compound 4-vinylbenzyl chloride (70 mg, 0.46 mmol) and N-tert-Butyl-N-(2-methyl-1phenylpropyl)-O-(1-phenylethyl)hydroxylamine (NMP initiator, 10 mg, 0.031 mmol) were
degassed by three freeze/thaw cycles, sealed under argon, and heated at 125 °C under argon
for 12 h. After the reaction cooled down to room temperature, the reaction mixture was
dissolved in DCM, and dialyzed against DCM/MeOH (v/v= 6/1) for 2 days. The solution
was collected and dried under vacuum to yield 290 mg (75% yield) of 1a. GPC
(PMMA/THF): Mn= 12K Da, Đ=1.5; Same method was applied for polymers 2a, 3a and
P4 except for feeding ratios. For 2a, compound M2 (200 mg, 0.77 mmol), M4 (163 mg,
0.46 mmol), 4-Vinylbenzyl chloride (47 mg, 0.31 mmol) were added. For 3a, compound
M2 (200 mg, 0.77 mmol), 4-Vinylbenzyl chloride (117 mg, 0.77 mmol) were added. For
P4, compound M2 (200 mg, 0.77 mmol), M4 (117 mg, 0.77 mmol) were added.
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Figure 2.13. 1 H NMR Spectrum of polymer 1a.

Figure 2.14. 1 H NMR Spectrum of polymer 2a.

Figure 2.15. 1 H NMR Spectrum of polymer 3a.
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Figure 2.16. 1 H NMR Spectrum of polymer P4.

Synthesis of polymers 1b-3b: Polymer precursors 1a was added to 2mL of
triethylphosphite in a round bottom flask and stirred with reflux at 110 °Cfor 24 h. The
reaction mixture was then cooled to room temperature and dialyzed against DCM/MeOH
(v/v= 6/1) for 2 days to remove excess triethylphosphite. The solution was collected and
dried under vacuum to yield 1b. 1H NMR indicates that there is a quantitative conversion
from benzyl chloride to benzyl phosphonate functional group. Same method was applied
for polymers 2b and 3b.

Figure 2.17. 1 H NMR Spectrum of polymer 1b.
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Figure 2.18. 1 H NMR Spectrum of polymer 2b.

Figure 2.19. 1 H NMR Spectrum of polymer 3b.

Synthesis of polymers P1-P3: Polymer 1b was dissolved in 3 mL of DCM in a
round bottom flask and stirred in an ice bath for 15 min. Bromotrimethylsilane (0.27 mL,
2.07 mmol) was slowly added to the solution. The reaction mixture was further stirred for
12 h. After the reaction, the solvent and excess bromotrimethylsilane was evaporated to
obtain dark yellow solids. 3 mL DCM was added to re-dissolve the compounds and 1 M
HCl aqueous solution (1 mL) was added. The reaction mixture was stirred at room
temperature for 1 hour. After the reaction, DCM was evaporated and water was removed
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by lyophilizing to obtain the final polymer P1. Same method was applied for polymers P2
and P3.

Figure 2.20. 1 H NMR Spectrum of polymer P1.

Figure 2.21. 1 H NMR Spectrum of polymer P2.
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Figure 2.22. 1 H NMR Spectrum of polymer P3.

Preparation of Zirconium (IV) Ion Loaded Polymeric Reverse Micelles
Reverse micelle solutions of polymer P1 were prepared by dissolving 0.7 mg of
polymer P1 in 10 mL toluene to obtain the phosphonate functional group concentration of
100 µM. ZrOCl2·8H2O was dissolved in water and added into the toluene solution at
different molar ratios of Zr to phosphonate group (0.1, 0.2, 0.5, 1, 2, 3 and 5). Sonication
was conducted until the solution became optically clear. Zr loaded reverse micelle solutions
of polymer P2-P4 were prepared in the same way to obtain 100 µM of phosphonate or PEG
groups. These solutions were used for the liquid-liquid extraction.

Preparation of Protein Digests
50 µM of α-casein and β-casein were dissolved in 50 mM NH4HCO3 (pH 8.2) and
digested for 12 h with trypsin at an enzyme-to-protein ratio of 1:100 (wt/wt). 50 µM of
chicken ovalbumin, BSA and lysozyme were dissolved in 50 mM NH4HCO3 (pH 8.2)
containing 8 M urea. DTT was added to a final concentration of 5 mM and the mixture was
incubated at 37 ºC for 1 h with gentle agitation to reduce the disulfide bonds in the proteins.
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IAM was added to a final concentration of 10 mM in the solution and was incubated at RT
for 30 min in the dark to alkylate the reduced disulfide bonds. DTT was added to obtain a
final concentration of 5 mM again and incubated at RT for 30 min in the dark to stop overalkylation. The solution was diluted with 50 mM NH4HCO3 to reduce the urea
concentration to 1.6 M. Trypsin was added at an enzyme-to-protein ratio of 1:100 and
incubated for 12 h at 37 ºC.

Liquid-Liquid Extractions
Protein digests were diluted with 50 mM Tris buffer and adjusted to the desired pH
using HCl or NH4OH. 200 L of the polymeric reverse micelle solution was added to 1
mL of the peptide solution and vortexed vigorously for 1.5 hours. Centrifugation at 15,000
rpm for 30 minutes was employed to break the resulting emulsion and separate the two
phases. The aqueous phase was removed, and the organic phase was dried by blowing N2
gas. This dried residue was re-dissolved in 20 L of THF and mixed with 20 µL of a DHB
matrix solution (25 mg/mL in 70% (vol/vol) acetonitrile containing 1% (wt/vol) H3PO4). 1
µL of this solution was directly spotted on the MALDI target for analysis.

Instrumentation
MALDI-MS analyses were performed on a Bruker Autoflex III time-of-flight mass
spectrometer. All mass spectra were obtained in negative linear mode and represent an
average of 400 shots acquired at 34% laser power with an accelerating voltage of 19 kV.
Dynamic light scattering (DLS) measurements were performed using a Malvern Zetasizer.
FT-IR spectra were recorded on a PerkinElmer Spectrum 100 FT-IR spectrometer. ICPMS data were obtained on a PerkinElmer Nexion 300 ICP mass spectrometer. Zr
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concentrations loaded into polymer P1 were determined by adding 0.5 mL of fresh aqua
regia for 30 min after evaporation of toluene in 10 L of polymer solutions. Zr
concentrations in aqueous phase after extraction were measured by directly adding 0.5mL
of fresh aqua regia into 100 L of the aqueous solutions for 30 min. The resulting solutions
were then diluted to 10 mL with deionized water for the ICP-MS measurements. A series
of Zr standard solutions (0, 0.2, 0.5, 1, 2, 5, 10, and 20 ppb) were prepared in 5% aqua
regia for calibration of ICP-MS measurements. 1H-NMR spectra were recorded on a 400
MHz NMR spectrometer using residual proton resonance of the solvents as internal
standard. Chemical shifts are reported in parts per million (ppm).
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CHAPTER III

SUPRAMOLECULAR NANOASSEMBLIES FOR GLYCOPEPTIDE
EXTRACTION AND RELEASE FOR MASS SPECTROMETRIC DETECTION

Introduction
Protein glycosylation plays an important role in biological process, such as cell
recognition,2 signaling pathways3 and development of genetic disorders.4 Also, it has
recently gained attention in the pharmaceutical industry as part of monoclonal antibody
drug characterization.5–7 The methods applied for glycosylation analysis are most often
based on mass spectrometry (MS), but because of the low abundance and heterogeneity of
glycosylated sites, separation prior to MS analysis is typically required.8–10
Efforts have been made to improve the separation of glycosylated proteins or
peptides through noncovalent and covalent interactions.9,11 Noncovalent interactions
include hydrophilic, lectin and chelation interactions that are relatively easy to incorporate
into online analysis before MS detection.11–14 Covalent binding using beads with boronic
acid or hydrazine/ hydrazide functional groups are also widely used because of their higher
specificity, which is essential for complex mixtures.15–20 For better selectivity and
efficiency in extraction, covalent and noncovalent interactions have also been used
complementarily. For example, Wang et al. used boronic acid nanoparticles for specific
binding with glycopeptides and poly(methyl methacrylate) nanobeads for non-specific
interactions with non-glycopeptides to achieve better selectivity.21 Also, glycoprotein
enrichment based on lectin affinity chromatography and on hydrazide chemistry have been
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used separately by Song, et al. to determine and confirm glycoprotein/glycopeptide
biomarkers in human blood serum more efficiently.22 Based on the continued need for both
high selectivity and efficiency in glycopeptide enrichment approaches, we designed a new
strategy that is inspired by the use of covalent and non-covalent interactions. Instead of
using both covalent and non-covalent interactions to target peptides, we used covalent
binding via hydrazide groups to achieve high selectivity for glycopeptide and a secondary
non-covalent interaction to catalyze this normally slow covalent binding reaction, thereby
improving extraction efficiency. We employ this strategy in a two-phase liquid-liquid
extraction platform because of its advantageous ability to extract, purify and concentrate
in one step.23,24 To achieve this two-phase extraction, we have designed a supramolecular
nanoassembly that can be readily tuned for optimal extraction efficiency. The
supramolecular nanoassembly described here is based on an amphiphilic polymer design
that we recently developed to selectively enrich phosphopeptides and other peptides
according to their isoelectric point.25–30 We find that in the confined environment of the
nanoassembly the reaction of hydrazide with glycans is faster than in existing approaches.
Moreover, the extraction efficiency can be further increased by placing functional groups
in the assemblies that catalyze the reaction of hydrazide moieties with glycans.

Results and Discussion
Glycopeptide Enrichment Using Hydrazide-Containing Nanoassemblies
The extraction procedure for glycopeptides by the hydrazide-containing
nanoassemblies is illustrated in Figure 3.1. IgG1, with its four well characterized glycans
on Asn292,30 was used as a model protein to evaluate the extraction performance of
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nanoassemblies of polymer P6 (Figure 3.2). Before enrichment, the two most abundant
glycopeptides from the IgG1 digest are detected (Figure 3.3a), while the other two
glycopeptides are not detected. After mild oxidation, enrichment with the nanoassemblies
and release, only the four glycopeptides are detected (Figure 3.3b). Some heterogeneity in
the detected glycopeptides is observed due to the oxidation reaction, but most of the glycan
information is retained after enrichment (Figure 3.4). The extraction selectivity is further
confirmed by PNGase F treatment of the enriched/released glycopeptides. Only a single
peptide containing the glycosylated residue Asn292 is measured after deglycosylation
(Figure 3.3c), indicating that only glycopeptides are extracted.

Figure 3.1. Workflow of glycopeptide enrichment using supramolecular nanoassemblies
and analysis using mass spectrometry.
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Figure 3.2. Structural features of polymer P1, P4, P6-P9.

Figure 3.3. MALDI-TOF mass spectra of the oxidized IgG1 tryptic digests before and
enrichment. (a) Mass spectrum before enrichment; (b) mass spectrum after enrichment
using nanoassemblies of the hydrazide polymer P1 at pH 4; and (c) mass spectrum after
enrichment and deglycosylation by PNGase F.
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Figure 3.4. Glycopeptide analysis before and after enrichment with polymer P6. (a)
Tandem mass spectrum of the precursor ion at m/z 2602.1 from the IgG1 digest and (b)
Tandem mass spectrum of m/z 2600.4 after oxidation and enrichment (b). Symbol: ( )
GlcNAc ( ) Mannose ( )Fucose.

Improved Enrichment Efficiency via Proximity-Assisted Reactivity
For more heterogeneous glycoproteins, enrichment using polymer P6 can
sometimes lead to relatively inefficient detection of some low level glycopeptides. As an
example, enrichment of HRP using nanoassemblies of P6 can enable the selective detection
of all 7 known glycosylation sites (Figure 3.5a), even though most are undetectable before
enrichment (Figure 3.5c), but some of the glycopeptides have low relative abundance. To
improve the enrichment efficiency, we hypothesized that a copolymer with both hydrazide
and weak acid functional groups would facilitate the binding in the nanoassemblies as the
hydrazide-aldehyde conjugation reaction is known to be catalyzed by an acid and conjugate
base.31 We reasoned that a nearby acid and conjugate base in the local microenvironment
would accelerate the reaction via a proximity-based effect. We tested this idea using mixed
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nanoassemblies with 10 nm diameters (Figure 3.5d) of polymer P6 and P1 (Figure 3.2). A
polymer containing phosphonate groups (i.e. polymer P1) was chosen because it is a
polyprotic acid with pKa values of 2.5 and 7.5 that could provide both acidic and conjugate
base functionality at the enrichment pH of 5.0. Upon extraction of the HRP digest by the
mixed nanoassembly, we find a significant intensity increase in the total ion intensity of
the glycosylated peptides (Figure 3.5b), and even detect new glycopeptides that are due to
enzymatic mis-cleavages that were not detected upon enrichment with nanoassemblies of
P6 (Figure 3.5a).

Figure 3.5. Enhanced glycopeptide detection after proximity-assisted enrichment. (a)
MALDI-TOF mass spectrum of an oxidized HRP tryptic digest after enrichment using
nanoassemblies of the hydrazide polymer P6; (b) MALDI-TOF mass spectrum after
enrichment using nanoassembly mixtures of hydrazide polymer P6 and phosphonate
polymer P1; (c) MALDI spectrum of oxidized HRP digests before enrichment. No
glycopeptides are detected; (d) Dynamic light scattering data for nanoassemblies formed
by polymers P6, P1 and P6+P1.
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Figure 3.6. Enhanced glycopeptide detection after proximity-assisted enrichment. (a) Total
intensity of glycopeptides extracted by nanoassemblies of P6 and of P6+P1, P6+P7 and
P1+P4; and (d) proposed proximity effects that improve the extraction efficiency of
glycopeptides.
Two sets of control experiments were employed to further test our hypothesis that
a nearby acid and conjugate base improve enrichment efficiency. Mixed nanoassemblies
of P6 and (i) a quaternary amine containing polymer, P7, that does not yield a proton or
conjugate base or (ii) an ethyleneglycol-containing polymer, P4, without acidic or basic
functionality were also studied. Using total glycopeptide intensity as an indicator of the
enrichment efficiency, we find that mixed assemblies with the phosphonate polymer P1
increase glycopeptide signal by almost a factor of 2 compared to P6 alone, while mixed
assemblies with polymers P7 and P4 decrease glycopeptide signal by factors of 3 and 2.3,
respectively (Figure 3.6a). The increased glycopeptide signal caused by the presence of P1
in the nanoassemblies together with the decreased signal in the presence of the other
polymers supports our hypothesis that nearby proton donors and acceptors are responsible

57

for the improved enrichment efficiency. We postulate that the improved efficiency is due
to proximity effects that accelerate the hydrazide-glycan conjugation reaction (Figure 3.6b).
To further understand how acidic functional groups in the polymer nanoassemblies
influence the enrichment efficiency, we synthesized polymers with carboxylate (P8) and
sulfonate (P9) groups (Figure 3.2) and tested their enrichment efficiencies as a function of
pH. These functional groups, along with the phosphonate functional groups, provide pKa
values that range from ~ -1 (-SO3H) to 7.5 (-PO3H-), providing a test of the importance of
both the acid and conjugate base functionality in enhancing the enrichment reaction. We
find that the enrichment efficiency is improved by forming mixed assemblies with all the
acidic polymers when the extraction is done at low pH (Figure 3.7). At higher pH values,
however, the enrichment efficiencies become more similar to the hydrazide assembly alone,

Figure 3.7. Total intensity of glycopeptides extracted from tryptic digests of oxidized HRP
at pH values ranging from 3 to 7 using nanoassemblies of P6, P6+P1, P6+P9 and P6+P8.
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suggesting that deprotonation of the acidic group leads to less enhancement. Interestingly,
the drop in the enhancement as the pH is increased is more extensive for the sulfonate
polymer (P9), which has the lowest pKa and is the least extensive for the phosphonate
polymer (P1), which has the highest pKa. Indeed, the phosphonate group has two acidic
protons causing its enhancement to exist over a wider range of pH values. As a whole,
these results provide additional evidence for a proximity-based effect in the
nanoassemblies that improve glycopeptide enrichment. These improvements, together with
previous work from our group using similar materials, highlights the advantages of using
supramolecular nanomaterials for peptide enrichment in general.

Extraction of Glycopeptides from Complexed Samples
With a better understanding of the polymer features that influence enrichment
efficiency, we then tested the ability of mixed nanoassemblies to extract trace-level
glycopeptides in a mixture. For this purpose, IgG1 and HRP were digested in the presence
of 100-fold molar excesses of BSA. Before enrichment of the protein digest mixture, no
glycopeptides for IgG1 or HRP can be detected (Figure 3.8a and d). After using
nanoassemblies of P6 (Figure 3.8b) or mixed nanoassemblies of P6 and P9 (Figure 3.8c),
the glycopeptide from IgG1 is selectively detected after release and deglycosylation, with
higher signal being observed for the mixed nanoassemblies. A similar effect is observed
for the glycopeptides from HRP. The mixed nanoassemblies containing P6 and P9 allow
the selective detection of more glycopeptides (Figure 3.8f) than the nanoassembly with
hydrazide polymer (P6) alone (Figure 3.8e). These results highlight the high degree of
selectivity possible with these supramolecular nanoassemblies. Future work will explore
the ability of these materials to selectively enrich even more complicated mixtures.
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Figure 3.8. Enrichment and sensitive detection of trace-level glycopeptides in protein
digest mixtures. (a) MALDI-TOF mass spectra of a tryptic digest of IgG1 (10 nM) and
BSA (1 µM) before enrichment; (b) after enrichment using nanoassemblies of polymer P6
at pH 4 followed by release and deglycosylation; and (c) after extraction using mixed
nanoassemblies of polymers P6 and P9 at pH 4 followed by release and deglycosylation.
(d) MALDI mass spectra of a tryptic digest mixture of HRP (50 nM) and BSA (5 µM)
before enrichment; (e) after enrichment using nanoassemblies of polymer P6 at pH 4
followed by release and deglycosylation; and (f) after extraction using mixed
nanoassemblies of polymers P6 and P9 at pH 4 followed by release and deglycosylation.

Conclusions
We have developed a simple method to improve glycopeptide enrichment
efficiency and MS detection using supramolecular nanoassemblies based on amphiphilic
polymers with hydrazide functional groups. The hydrazide-containing polymer itself forms
nanoassemblies that are highly selective for oxidized glycopeptides. Co-assembly of the
hydrazide polymer together with acidic polymers further improve enrichment efficiency
via a proximity effect that catalyzes the hydrazide-glycan conjugation reaction. Using the
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nanoassembly mixtures allow the selective and efficient enrichment and detection of
glycopeptides that are present at low levels in mixtures. This study further demonstrates
the value of designer supramolecular materials based on amphiphilic polymers as a
platform for enriching and detecting biomolecules of interest. Future work will apply these
nanoassemblies for the detection of glycosylated peptides or proteins in cell lysate, which
would make them valuable materials for glycoproteomics studies.

Experimental Section
Materials and Reagents
Horseradish peroxidase (HRP), bovine serum albumin (BSA), DL-dithiothreitol
(DTT), iodoacetamide (IAM), trifluoracetic acid (TFA) and potassium acetate were
obtained from Sigma-Aldrich. The monoclonal antibody (IgG1) was purchased from
Waters. PNGase F was obtained from New England Biolabs. Trypsin was purchased from
Promega. Sodium periodate, 2, 5-dihydroxybenzoic acid (DHB), MOPS, acetic acid,
toluene, tetrahydrofuran (THF) and acetonitrile (ACN) were purchased from Fisher
Scientific. Urea was purchased from MP Biomedicals. Ammonium bicarbonate
(NH4HCO3) was obtained from Fluka. THF was distilled before use. Water was purified
using a Milli-Q water purification system. All chemicals were used as received from
commercial sources.
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Polymer Synthesis, Self-assembly and Co-assembly in Toluene

P0

P6

Figure 3.9. Synthesis of amphiphilic random copolymer P6.

Synthesis of Polymer. Polymer P0 was prepared according to previous
procedures.27 P0 (100 mg) and carbonyldiimidazole (61 mg, 2 equivalents of carboxylate
group) were dissolved in 5 mL tetrahydrofuran and stirred at room temperature for 2 hours.
Then, this mixture was added to a hydrazine monohydrate/THF (2 mL/2 mL) solution
dropwise and allowed to reflux overnight. The solvent was removed by a rotavapor, and
the crude oil was purified by precipitating it 3 times in methanol. Yield: 90%, GPC (THF)
Mn: 11.5 K. Đ: 1.08. 1H NMR (400 MHz, CDCl3): δ 6.57-6.2, 4.53, 3.89, 1.77, 1.48-1.26,
0.90. 13C NMR (100 MHz, CDCl3) δ 157.1, 128.5, 114.2, 67.9, 31.9, 29.6, 29.3, 29.1, 26.2,
25.5, 22.7, 14.1. From 1H NMR, integration of the proton peaks at 0.90 ppm and 4.53 ppm
confirmed the molar ratio of these two components to be 53:47.
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Figure 3.10. 1 H NMR Spectrum of polymer P6.

The hydrazide functional group attachment was confirmed by IR (Figure 3.10)
showing a broad peak at 3319 cm-1 corresponding to N-H bond, C=O bond shift from 1731
cm-1 to 1693 cm-1 due to the conversion of -OH to -NHNH2.

Figure 3.11. FT-IR of polymer carboxylate polymer P0 and hydrazide polymer P6.
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Polymers P1, P4 and P7-P9 were synthesized as previously described.25,28,29
Nanoassembly solutions of individual polymers were prepared by dissolving solid
polymers in toluene. Nanoassemblies of co-assembled polymers were prepared by mixing
their already prepared nanoassembly solutions. The concentration of P6 is 0.3 mg/mL and
of P1, P4 and P7-P9 are 0.6 mg/mL. Dynamic light scattering on the resulting polymer
solutions after self-assembly and co-assembly were conducted (Figure 3.5d).

Protein Oxidation and Digest
To facilitate enrichment of the glycosylated peptides by the hydrazide-containing
nanoassemblies, samples of 0.5 mg of IgG1 or 1 mg of HRP were mildly oxidized with 10
mM sodium periodate in 1 mL of 0.1 M sodium acetate buffer at pH 5.5 to produce free
aldehydes capable of reacting with hydrazide. Samples were incubated in the dark at room
temperature for 30 min and then were washed 3 times and desalted by a 10 kDa molecular
weight cutoff filter to remove excess periodate before digestion. To prepare the samples
for proteolytic digestion, they were dissolved in 500 µL denaturing buffer containing 8 M
urea, 50 mM NH4HCO3 and 5 mM DTT and incubated for 1 h at 37 °C with gentle agitation
to reduce the disulfide bonds in the proteins. The protein solutions were brought to room
temperature and 10 mM IAM was added into the solutions, before incubating in the dark
at room temperature for 30 min to alkylate the reduced disulfide bonds. 5 mM DTT was
added again, and the samples were incubated in the dark at room temperature for another
30 min to stop overalkylation. The solutions then were diluted with 50 mM NH4HCO3 to
reduce the urea concentration to 1.2 M. Trypsin was added at an enzyme-to-protein ratio
of 1:50 and incubated for 12 h at 37 °C. BSA was digested in the same manner as the other
proteins.
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Liquid-Liquid Extraction and Release
Before extraction with the nanoassemblies, the protein digests were diluted to the
desired pH and concentration. 200 µL of the nanoassembly solution was added to 500 µL
of the protein digest and vortex mixed vigorously for 30 min. The sample was incubated
in a sand bath at 50 °C for 1 h, vortexed again for 30 min, and then incubated again at 50 °C
for 1 h. After extraction, centrifugation at 14000 rpm for 30 min was used to separate the
two phases. The aqueous phase was removed, and 500 µL of fresh acetate buffer was added
to wash the organic phase by mixing the two phases for 30 min and removing the aqueous
phase after centrifugation. The organic phase was dried by vacuum centrifuge. 300 µL of
THF was added to break the supramolecular assembly and 200 µL of MOPS buffer (pH 7)
was added to wash the polymer thoroughly. Then, the THF was evaporated and aqueous
phase was removed. To release the glycopeptides from the polymer, the dry residue was
re-dissolved in 300 µL of fresh THF and 200 µL of 0.1 M HCl was added to hydrolyze the
hydrazone group between the polymer and the glycopeptides. The mixture was incubated
for 1 h at 60 °C to complete peptide release. The aqueous phase with released glycopeptides
was collected after centrifugation. Before adding PNGase F, vacuum centrifugation was
used to remove the remaining THF, and the pH was adjusted to 8.4 in 50 mM NH4HCO3.
1 µL of PNGase F was then added to 20 µL of the peptide solution and incubated at 37 °C
with gentle agitation for 12 h.

Mass Spectrometry Analysis
The peptide solutions resulting from nanoassembly enrichment before and after
deglycosylation were analyzed by MALDI-MS. 0.5 µL of peptide solution was mixed with
0.5 µL of DHB matrix solution (25 mg/mL in 70% ACN, 29% H2O and 1% TFA) and
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spotted on MALDI target for analysis. MALDI analysis was performed on a Bruker
UltrafleXtreme MALDI-TOF/TOF. Spectra were obtained in positive ionization mode
using reflectron detection with a repetition rate of 2 kHz and an acceleration voltage of 20
kV. Peptides were identified using MS/MS using the LIFT mode33 at a 1 kHz laser
repetition rate, applying 7.5 kV for initial acceleration of ions and 19 kV for reacceleration
of the product ions in the LIFT cell. 5000 laser shots were accumulated per spectrum.
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CHAPTER IV

SELECTIVE CAPTURE AND CONTROLLED RELEASE OF PEPTIDES USING
AMPHIPHLIC NANOASSEMBLIES

Introduction
Peptide-based drugs fill a gap between traditional small molecule therapies and
more recent protein therapies and biologics. Compared with small molecules, peptides have
higher efficacy, safety and tolerance in the human body, and their production complexity
and cost are lower than protein-based biopharmaceuticals.1-4 Therefore, peptides are
becoming more and more attractive as potential drug candidates. Whether peptides are
made by solid phase synthesis, solution phase synthesis or purified from natural sources,
most peptides begin as part of complex mixtures that require purification.5-8 Although
solid-phase synthesis reactions can be carefully controlled, impurities are inevitably
formed, and often include missing, truncated or chemically modified sequences resulting
from cleavage of adducts or other by-products formed during processing.9-12 For peptide
therapeutics, purity and target peptide yield are key factors to be considered, which offer
great challenges in the development of peptide separation methods. Often, the goal of a
given separation strategy is to rapidly purify peptides with the highest degree of purity. For
typical laboratories that synthesize many different peptides, it is useful to establish a
standard purification protocol that can be used for most samples while allowing for simple
optimization when necessary.
Reversed-phase chromatography is by far the most popular peptide purification
method due to its reliability and wide applicability. C18-bonded silica is the most common
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reversed-phase column packing, but other stationary phases, such as C4, C8 and phenyl
groups, can also provide alternative selectivity for optimizing peptide separation.9,13-15
Though reversed-phase chromatography is commonly used, some peptides can be more
efficiently separated by other selective methods such as ion-exchange or size-exclusion.
Ion exchange chromatography can be used for peptide separation because the amino acids
in the peptide can be either positively charged or negatively charged. Size-exclusion
chromatography (SEC) separates molecules based on their molecular size rather than
chemical properties such as charge or polarity. It is a low-resolution technique, and the
resolution can be affected by the volume and concentration of the sample.14 SEC is
generally not effective for separating peptides of similar size. Due to their limitations, these
other separation techniques are sometimes combined with reversed-phase chromatography
to create a two-step process for the purification of difficult samples.
While numerous separation techniques are available for different purposes, they are
usually require specialized instrumentation, for example, the most commonly used HPLC.
Simpler approaches for the isolation of desired peptides are needed. Here, we describe
polymeric supramolecular assemblies that can purify peptides based on their chemical
characteristics, including attributes such as isoelectric point (pI) or modifications.15-18
Through selective capture and sequential release, peptides can be isolated by the selfassembling nanoassemblies (Figure 4.1). These nanoassemblies, formed by amphiphilic
polymers that consisting of a styrene scaffold and a functional group, can combine the
advantages of the separation techniques for good separation efficiency. They can work over
a wide pH range, and the self-assembly feature of these materials allows for flexibility of
simple optimization for peptides that are difficult to separate.
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Figure 4.1. Selective capture and controlled release of peptides using amphiphilic
nanoassemblies.

Results and Discussion
Selective Capture and Release of Peptides based on Charge
To develop a means of selectively isolating peptides of interest, we first explored
separations based on peptide charge. In previous work, we had demonstrated that peptides
could be selectively extracted from an aqueous phase into an organic phase by utilizing the
isoelectric point (pI) of peptides and the aqueous phase pH. In this work, we investigated
whether peptides extracted into an organic phase could be selectively released back into an
aqueous phase having a different pH. A mixture of seven peptides with pI values ranging
from 3.37 to 12.4 were chosen to test this possibility (Figure 4.2). After extraction of the
peptide mixture at pH 6 using polymer P1, the two negatively charged peptides with pI
values < 6 are left in aqueous phase because of the charge repulsion they experience with
the phosphonate groups of polymer P1 (Figure 4.2c). In contrast, the five positively-charge
peptides with pI values > 6 are extracted into the organic phase because of their
complementary charge (Figure 4.2d). This extraction behavior is identical to previous work
with reverse micelle-like nanoassemblies containing negatively charged hydrophilic
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groups.20 To test the possibility of selectively releasing some of the peptides from the
organic phase, a fresh aqueous phase at pH 9.5 was mixed with the organic phase
containing the five peptides in the nanoassemblies of polymer P1. We predicted that the
two peptides with pI values below 9.5 would be released into the new aqueous phase as the
pH of the water pool inside the nanoassemblies equilibrated with the new aqueous phase
and changed the charge state of these peptides. The two peptides with pI values of 7.91 and
6.92 would become negatively charged, causing repulsion with the negatively charged
phosphonate groups in the interior of the nanoassemblies. Indeed, upon analyzing the new

Figure 4.2. MS analysis of peptides before and after separation using polymer P1. (a)
Structural features of polymer P1; (b) MALDI mass spectrum of peptide mixture before
extraction. The peptides include bradykinin (pI 12.40), kinetensin (pI 11.13), angiotensin
I (pI 7.91), β-amyloid 1-11 (pI 4.04), β-amyloid 10-20 (pI 6.92), malantide (pI 10.69) and
preproenkephalin (pI 3.37); (c) MALDI mass spectrum of peptides left in aqueous phase
after selective extraction by polymer P1 at pH 6; (d) MALDI mass spectrum of peptides
extracted into the organic phase by polymer P1 at pH 6; (e) MALDI mass spectrum of
peptides selectively released from the organic phase containing polymer P1 into a new
aqueous buffer of pH 9.5; (f) MALDI mass spectrum of peptides left in polymer phase after
release at pH 9.5.
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aqueous phase after peptide release, we detect only the two peptides in this phase (Figure
4.2e). The nanoassemblies in the organic phase remain intact as the other positively
charged peptides remain in the organic phase (Figure 4.2f). In effect, two selective capture
steps and one controlled release step offer an opportunity to separate the seven peptides
into three separate groups according to pI: (1) pI < 6; (2) 6 < pI < 9.5; and (3) pI > 9.5.

Sequential Release Peptides for Peptide Isolation
We also explored the possibility of sequentially releasing peptides one-by-one via
a step-wise increase in the pH of the aqueous buffer that was mixed with the organic phase
containing the extracted peptides. This approach is illustrated with a three-peptide mixture
(Figure 4.3). From an aqueous solution of pH 3, β-amyloid 1-11, β-amyloid 1-16 and
ACTH 1-13 were extracted by polymer P1 (Figure 4.3a) as the net charge of the peptides
is positive (Figure 4.3b). After mixing the polymer phase with an aqueous phase at pH 5,
β-amyloid 1-11 was selectively released (Figure 4.3c) since the net charge of this peptide
became negative, which is repulsive to the polymer phase. Upon further sequential mixing
of the remaining polymer phase with new aqueous phases at pH 9 and pH 11, β-amyloid
1-16 and ACTH 1-13 were selectively released and isolated (Figure 4.e and g). This peptide
isolation method is easily operated in the two-phase liquid-liquid separation technique. An
interesting observation is that the release behavior of these peptides as a function of pH
follows the trend that would be expected for the negatively-charged species of these
peptides based on the pKa values of their different functional groups (Figure 4.3d, f, and
h). As the pH of the aqueous phase is increased, the peptides are released as they become
negatively-charged, although there is a slight shift to higher pH values, which is likely
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attributed to increases in the pKa of the peptide functional groups upon interacting with the
phosphonate groups in the polymer.

Figure 4.3. Sequential release of peptides into new buffer and their release behavior study.
(a) MALDI mass spectrum of β-amyloid 1-11, β-amyloid 1-16 and ACTH 1-13; and (b)
their net charge distribution over pH. c) MALDI mass spectrum of β-amyloid 1-11 being
isolated at the first releasing pH 5 and (d) its release behavior is studied from pH 3 to 6; (e)
MALDI mass spectrum of β-amyloid 1-16 isolated at the second releasing pH 9 and (f) its
release behavior is studied from pH 4 to 12; and (g) MALDI mass spectrum of the ACTH
1-13 isolated at the third releasing pH 11 and (h) its release is studied from pH 4 to 12.

When this peptide isolation method was further evaluated with mixtures containing
several peptides with high pI values, it was found that the high pI peptides could not be
properly released. As an example, when the peptides ACTH 1-13, ACTH 6-24 (pI 12.2),
and bradykinin (pI 12.4) are in a mixture, ACTH 6-24 and bradykinin are released at pH
values that are too low (Figure 4.4a). This unexpected release was attributed to the
instability of polymeric nanoassemblies at high pH.20 Therefore, polymer P10 was
synthesized (Figure 4.4b), as we previously found that polymers with a lower percentage
of the negatively-charged functional group could maintain their stability and ability to bind
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positively-charged peptides in the organic phase when exposed to aqueous phases with
high pH values.20 The greater stability of polymers like P10 at higher pH is thought to be

Figure 4.4. The capture and release ability of nanoassemblies formed by different
amphiphilic polymers. (a) Unexpected release of high pI peptides ACTH 6-24 (pI 12.2)
and bradykinin (pI 12.4) from nanoassemblies formed by polymer P1 at high pH; (b)
Structural features of polymer P10 and ACTH 1-13 (pI 9.3) cannot be properly released by
overly stable nanoassemblies formed by polymer P10 and (c) MALDI spectra of peptides
separated using acetonitrile as co-solvent by P10, which cannot be separated by polymer
P1 due to the unexpected release (d).
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due to the decreased charge density in the interiors of the nanoassemblies when the high
pH causes almost complete deprotonation of the phosphonate groups. While
nanoassemblies of P10 are more capable of binding peptides at high pH, release from P10
is not efficient (Figure 4.4b) as it barely releases any ACTH 1-13 (pI 9.3) even at pH 11.5,
as compared to the release of ACTH 1-13 starting at pH 10 using polymer P1 (Figure 4.3h).
However, by modifying the release solution with 10% acetonitrile, which has a polarity
between toluene and water, we are able to disrupt the nanoassembly of polymer P10 to a
greater extent and release peptides more effectively, while maintaining release selectivity.
With the addition of 10% acetonitrile, ACTH 1-13 can now be separated from ACTH 6-24
by selective release at pH 10.89 (Figure 4.4c), while the same separation could not be
achieved by polymer P1 under the same release conditions, due to the unexpected release
of ACTH 6-24 (Figure 4.4d). These results highlight the flexibility of this method for
simple optimization.
The performance of the method on separation of a complex mixture was evaluated
using BSA digests (Figure 4.5). After forward extraction of a BSA digest (Figure 4.5a) at
pH 4 using polymer P1, primarily peptides with pI values < 4 remained in the aqueous
phase (Figure 4.5b), while peptides with pI > 4 were extracted and enriched (Figure 4.5c).
The organic phase containing the reverse micelles and extracted peptides was then mixed
with a new aqueous solution at pH 6, and primarily peptides with pI values between 4 and
6 were released (Figure 4.5d). Because BSA has a pI of 5, a large number of peptides were
released. Mixing the remaining polymer phase with an aqueous solution at pH 8, further
releases more peptides, including ones that were ineffectively released at the lower pH
(Figure 4.5e and f). After these extraction and releases, the peptides in the BSA digest were
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in effect sorted according to their pI values. In addition, because the mixtures were
simplified along the way, overall more peptides (34 vs. 29) are detected as compared to the
direct analysis by MALDI (Figure 4.5a). From the data in Figure 4.5, it is clear that the pIbased separation is not perfect because other factors, such as peptide hydrophobicity, have
not been taken into account yet, but 76% of the peptides are sorted according to their pI
values. Future work will investigate the peptide-dependent release behavior for more
complex mixtures to determine if selective release from even more complicated digests is
possible.

Separate Peptides of Protein Digests

Figure 4.5. MS analysis of protein (BSA) digest separation by selective extraction and
controlled release. (a) MALDI mass spectrum of direct analysis of BSA digests; (b)
MALDI mass spectrum of peptides left in aqueous phase after extraction at pH 4 using
polymer P1; (c) MALDI mass spectrum of peptides extracted by polymer P1 at pH 4; (d)
MALDI mass spectrum of peptides first released at pH 6 and further released at pH 8 from
organic phase and (f) MALDI mass spectrum of peptides left in organic phase after
sequential release.
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Conclusions
We have developed a simple method that can selectively capture and controllably
release peptides from peptide mixtures. This new method relies on anionic polymeric
nanoassemblies that bind and release peptides based on charge complementarity. The
materials can isolate peptides through sequential release of a mixture of extracted peptides,
and the release pattern follows closely to the calculated fractional composition of the
negatively-charged species. Release of high pI peptides and high pH values requires
optimization of the polymer architecture and the release buffer to ensure efficient release
of high pI peptides. Future work will apply these methods for peptide purification after
solid-phase peptide synthesis.

Experimental Section
Materials and Reagents
Peptides bradykinin (RPPGFSPFR, MW 1060), kinetensin (IARRHPYFL, MW
1172), angiotensin I (DRVYIHPFHL, MW 1296), β-amyloid 1-11 (DAEFRHDSGYE,
MW

1325),

β-amyloid

10-20

(YEVHHQKLVFF,

MW

1446),

malantide

(RTKRSGSVYEPLKI, MW 1633), preproenkephalin (SSEVAGEGDGDSMGHEDLY,
MW 1954) and ACTH 6-24 (HFRWGKPVGKKRRPVKVYP, MW 2336) were acquired
from

the

American

Peptide

Company.

Peptides

β-amyloid

1-16

(DAEFRHDSGYEVHHQK, MW 1955) and ACTH 1-13 (SYSMEHFRWGKPV, MW
1624) were purchased from Bachem Company. Bovine serum albumin (BSA), DLdithiothreitol (DTT), iodoacetamide (IAM), trifluoracetic acid (TFA) and potassium
acetate were obtained from Sigma-Aldrich. BSA digests were obtained according to our
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previously reported procedure.21 Trypsin was purchased from Promega. Sodium periodate,
sodium phosphate, 2, 5-dihydroxybenzoic acid (DHB), acetic acid, toluene,
tetrahydrofuran (THF) and acetonitrile (ACN) were obtained from Fisher Scientific. Urea
was purchased from MP Biomedicals. Ammonium bicarbonate (NH4HCO3) was obtained
from Fluka. Water was purified using a Milli-Q water purification system. THF was
distilled before use. All other chemicals were used as received from commercial sources.

Polymer Synthesis and Nanoassembly Formation in Toluene
Polymers P1 and P10 were synthesized as previously described.20,21 The
nanoassembly solution of polymer was prepared by dissolving the polymer in toluene at
the concentration of 1 mg/mL. The solution was sonicated until clear before being used for
the two-phase liquid-liquid extraction.

Peptide Extraction and Selective Release
Before extraction with the nanoassemblies, the peptide mixture or protein digests
were diluted to the concentration of 1 µM and to the desired pH. 200 µL of the
nanoassembly solution was added to 1 mL of the peptide solution and vortex mixed
vigorously for 1.5 h. After extraction, centrifugation at 13000 rpm for 20 min was used to
separate the two phases. The aqueous phase was removed for MS analysis, and 1 mL of
fresh buffer with desired pH was added to the left organic phase and shaken for 1 h for
selective release. Centrifugation and peptide release were repeated as needed to accomplish
sequential release of different peptides.
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Mass Spectrometry Analysis
The peptide solutions resulting from the nanoassembly separations were analyzed
by MALDI-MS. 0.5 µL of peptide solution was mixed with 0.5 µL of DHB matrix solution
(25 mg/mL in 70% ACN, 29% H2O and 1% TFA) and spotted on MALDI target for
analysis. MALDI analyses were performed on a Bruker Autoflex III time-of-flight mass
spectrometer. All mass spectra were obtained in positive reflectron mode and represent an
average of 300 shots acquired at 45% laser power with an accelerating voltage of 19kV.
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CHAPTER V

CONCLUSIONS AND FUTURE DIRECTIONS

In this dissertation, amphiphilic nanoassemblies were utilized to selectively enrich
peptides of interest from complex mixtures through modification-specific and
complementary charge-based interactions. In chapter II, the selectivity of the polymeric
nanoassemblies was easily changed from pI-based interactions into phosphonate-metal(IV)
chelation-based extraction by loading metal ions into the supramolecular nanoassemblies.
This means that this material has a broad application in biomarker study as a simple
optimization of the material allows for the study of a new type of biomarkers. Besides the
flexibility of changing its affinity to peptides, the extraction selectivity and efficiency of
the material can also be easily optimized at the molecular level. By evaluating the
performance of the Zr loaded nanoassemblies on the phosphopeptide extraction under
different conditions such as varying the amount of metal ion loading or changing the
polymer structure, we found that an optimal chemical interactions between polymer
functional groups, metal ion and phosphopeptides can provide the best extraction result.
Though it has been commonly agreed that metal (IV) ions offer the best selectivity
targeting phosphopeptides, how the metal ions are loaded to nanomaterials vary greatly.
Previous work has mostly accomplished this by loading metal ions to polymers having
phosphate group on the surface of the magnetic beads, which is easy for the phase
separation after the extraction of phosphopeptides, while loading and maintaining the metal
ions need harsh conditions, like very low pH to minimize hydrolysis of the metal ions.1,2
However, loading metals ions into the amphiphilic nanoassemblies with the phosphonate
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groups inside of the material provides a new possibility of keeping the metal ions balanced
between being protected from hydrolysis and becoming accessible for phosphopeptide
binding. However, comparing to the materials that have been applied to centrifuge filters
or HPLC columns,2 metal-loaded nanoassemblies still require more systemic studies for
wider application in mass spectrometry experiment.
A promising direction following the work in Chapter II would be to develop ways
to enrich phosphorylated proteins since some phosphorylation happens only on a specific
proteoform.3,4 Specific detection of phosphorylated proteins would provide a potentially
powerful way to measure biomarkers that cannot be unambiguously detected at peptide
level. Our method has shown good extraction performance over a broad pH range from
acidic to physiological pH, which then has the potential to study a broad range of
biomarkers from gastric acid (pH = 1.0-2.0) to urine (pH = 5.0-7.5), and to human milk
(pH = 6.9-7.0 ) and blood (pH = 7.35-7.45). More importantly, these extractions could be
done without disturbing the structure of the biomarker proteins. We are also encouraged
by a recent study by our collaborator who has shown that these supramolecular
nanoassemblies can transport proteins from aqueous phase to organic phase through
electrostatics and ligand-protein interactions and maintain the tertiary structure and
function of the transported proteins.5 Therefore, extraction of the intact phosphorylated
protein, coupled with top-down MS approach has a very good potential in providing
information of a specific proteoform biomarker.
Another interesting direction would be applying the metal-loaded nanoassemblies
to on-line separation strategies, which would allow us to quantitatively analyze biomarkers
more efficiently and with better reproducibility, especially for analyzing large numbers of
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samples for reliable comparison between diseased and normal patient groups. A monolithic
HPLC column can provide both the nanoassembly structure and its function in targeting
phosphopeptides. Also, our new understanding about the chemistry between metal,
phosphopeptides, and the phosphonate/PEG groups would allow currently available online
phosphopeptide enrichment strategies work in a broader pH range and in milder conditions.
To further explore the possibility of using this material in targeting types of
biomarkers with heterogeneity like glycopeptides, we utilized a covalent binding-based
interaction in the supramolecular system for higher selectivity and a non-covalent
interaction for higher extraction efficiency (i.e. chapter III). Both the covalent and noncovalent interactions have been explored in the previous glycopeptide enrichment studies.610

Non-covalent interactions, such as hydrophilic, lectin and chelation-based interactions

are widely used as they can be easily incorporated into column-based separation
methods.6,7 Covalent binding using hydrazide chemistry or boronic acid recognition are
also used because they can offer better selectivity than non-covalent interactions.8,9 We
then provided a strategy that combines these two interactions in a way different from
previous work. Most previous work has used non-covalent and covalent interactions in
sequence, which limits how much the chemical interactions in peptide binding can improve
enrichment efficiency. For example, Song, et al used lectin affinity chromatography and
hydrazide chemistry separately and so be able to determine and confirm glycopeptide/
glycoprotein biomarkers in human blood serum.10 However, using non-covalent and
covalent interactions at the same time provides the opportunity to improve enrichment
efficiency in a way that is not just additive. As our work is in the early development stage,
it may require more studies to obtain new scientific insight for its further development.
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In chapter III, nanoassembly containing hydrazide functional groups was designed,
which showed selective covalent interactions to peptides modified with glycans. Coassembled with the hydrazide polymer, acidic polymers in the micro extraction
environment were found to be able to facilitate the reaction between hydrazide polymer
and the oxidized glycans on the glycopeptides. These co-assembled polymers provide
adjacent proton donors and conjugate base functionality that are needed in the coupling
reaction. These encouraging results show that not only can we improve the selectivity by
utilizing different chemical interactions in the supramolecular system, but also, we can
catalyze the binding reaction once nanoassemblies interact with low abundant biomarkers,
which could significantly improve the biomarker recovery. Although nanoreactors have
been well studied mainly due to high reaction efficiency,11 they are not used in peptide
enrichment, while our work shows the possibility of utilizing that strategy in high specific
binding of biomarkers using supramolecular materials in the future.
Another significant difference of our method comparing to most currently available
glycopeptide enrichment methods is that after extraction of the glycopeptides to their
nanomaterials, an enzyme has to be added to the aqueous phase so that peptides, free of
glycans, can be collected for MS analysis. Though, by our method, glycopeptides are
released from polymer by acid and so that the glycans can be analyzed on the peptide
sequence. This means of analysis is important for peptide biomarkers when we need the
information about what specific sugar composition on a specific amino acid sequence, but
we found that removing glycans from peptides after releasing them with acid allows more
sensitive MS detection. Therefore, it would be interesting and more efficient if we could
release the peptides from glycans in the reverse micelles after extraction. Perhaps this
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release could even be more efficient in the confined environment of the reverse micelles.
A future work following the studies described in Chapter III could be to load the enzyme
peptide-N(4)-(N-acetyl-beta-D-glucosaminyl)asparagine amidase F (PNGase F) into
separate reverse micelles and then merge these loaded reverse micelles with those reverse
micelles having the extracted glycopeptides. If the two sets of reverse micelles could merge
effectively, PNGaseF could be transferred into the micelles with the glycopeptides,
allowing them to be deglycosylated. Subsequent analysis of these deglycosylated peptides
could then benefit from the enhanced MALDI-MS analysis that occurs due to ‘hot spot’
formation.12 The optimal working pH of the PNGaseF is pH 7.4, and the pI of the enzyme
is 8.3, so it is positively-charged at the working pH. Therfore, a negativley-charged
polymers like the phosphonate polymer, which also improves the reaction efficiecy of
hydrazide and glycan, can be used for the extraction of PNGase F. Another option could
be modifiying PNGase F with a tag like glutathione-S-transferase (GST) by expressing it
as a GST fusion protein and then glytathione-containg nanoassemblies that have affinity
for GST could be used for the extraction of PNGase F.13
Besides selective extraction, the possibility of controlled release was studied with
amphiphilic nanoassemblies in Chapter IV, which could be very useful in sorting
biomarkers into different categories and even isolating one specific biomarker for more
careful study. This method was investigated with complementary charge-based interactions
as peptides are either positively charged or negatively charged and their net charges are
affected by the pH of environment. By taking advantage of that feature, we can change the
charge state of the peptides and let them be extracted and sequentially released. This idea
was proved successful in peptide isolation from relatively simple mixture and show a good
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potential for peptide sorting from complex mixtures like protein digests. In addition, this
method has shown great potential in peptide isolation after solid-phase synthesis, which
could be a follow up application in the future.
In summary, these studies demonstrate that supramolecular materials formed by
amphiphilic polymers can be readily designed to selectively target a broad range of
biomarkers. The performance of these materials has been preliminarily evaluated in peptide
mixture, and their performance in enriching protein biomarkers are expected to be
evaluated in more complex samples like serum and cell lysates in the future. Especially,
more enzyme loading work needs to be studied as it will open more possibilities, besides
the reaction with extracted glycopeptides, other modifications, such as ubiquitination,
which requires more specific ubiquitin receptors with tertiary structure can also be
investigated by this method. In addition to exploring new science using these
supramolecular nanoassemblies, they also show good potential as separation materials.
Investigations of the relationship between polymer structure and their resulting
performance has provided us novel insight so we can develop more efficient biomarker
enrichment strategies that could one day allow us to diagnose some diseases at an earlier
stage.
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